[1]. Ayele A., Seyoum Z. Review on canine leishmaniasis, etiology, clinical sign, pathogenesis, treatment and control methods. Global Veterinaria. 2016;17(4):343–352.
[2]. Gashaw enbiyale, demeke Debalke, endris Aman, birhanu Eedmim. Review on Leishmaniasis. Journal of American Science. 2018;142: 67-73.
[3]. Zarati S, Sobhan Fayez S., Hamid Sedighian H. Production of new a nanovaccineand evaluation ofit'sEffectsonbalb/c ratswith L.major. Journal of Sabzevar University of Medical Sciences, 2015 ; 21(6) : 1182-93.
[4]. Macconkey S.E.,Lopez A.,Shaw D.,Calder J. leishmanial polyarthritis in a dog. Canine Vet J. 2002; 43: 607-60.
[5]. Gavgani AS, Mohite H, Edrissian GH, Mohebali M, Davies CR. Domestic dog ownership in Iran is a risk factor for humaninfection with Leishmania infantum. Am J Trop Med Hyg. 2002; 67(5):511-5.
[6]. Sundar S. Visceral leishmaniasis. Tropical Parasitology.2015; 5( 2): 83–85.
[7]. Mcgwire B C , a.r. Satoskar A R. Leishmaniasis: clinical syndromes and treatment. An International Journal of Medicine . 2013; 107:7–14.
[8]. Uliana S R , Trinconi C T, Coelho A C , Chemotherapy of leishmaniasis: present challenges, Parasitology. 2018; 145( 4): 464–480.
[9]. Oryan A , Akbari M. Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine.2016 ; 9(10): 925–932.
[10]. Hosseini SM, Hatam GR, Ardehali S. Characterization of Leishmania isolated from unhealed lesions caused by leishmanization. East Mediterr Health J. 2005;11(1-2):2403.
[11]. Control of the leishmaniases. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 2010;949:1202.
[12]. Mandira, M., Anindita, B. and Swadesh, D. Monoclonal antibody affinity purification of a 78 KDa membrane protein of Leishmania donovani of Indian origin and its role in host –parasite interaction. Indian. Academy. Science.2002; 27:665-672.
[13]. Schmitz K, Geisslinger G, Tegeder I. Monoclonal antibodies in preclinical EAE models of multiple sclerosis: A systematic review. Int J Mol Sci. 2017;18:1–18.
[14]. Tomita M, Tsumoto K: Hybridoma technologies for antibody production. Immunotherapy. 2011; 3: 3 71–380.
[15]. Abdalla H S, Eltahir A G K, Samia A O, Hamid S A. Innovative serum-free medium for in vitro cultivation of promastigote forms of Leishmania species. Parasitology International. 2008;57: 138–142. [16]. Jervis S, Chapman L. A. C. , Dwivedi S, et al.Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India.Parasites & Vectors.2017; 10(1): 601.
[17]. Fadili K, Messier N, Leprohon P. Role of the ABC transporter MRPA (PGPA) in antimony resistance in leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemoter. 2005; 49 (5):1988-1993. [18].
[18]. Tavaresa J b, Ouaissic A. , P.K.T. Lind, Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotes. Int J Parasitol.2005; 35 :637–646. [19]. Nasereddin A, Schweynochb C, Schonianb G, Jaffe JL. Characterization of Leishmania (Leishmania) tropica axenic amastigotes. Acta Tropica. 2010;113:72–79.
[20]. Nejad-Moghaddam A, Abolhassani M. Production and characterization of monoclonal antibodies recognizing a common 57-kDa antigen of Leishmaniaspecies. Iran Biomed J. 2009; 13:245-51.
[21]. Justin L , The History of Monoclonal Antibody Development - Progress, Remaining Challenges and Future Innovations. Annals of Medicine and Surgery.2014; 3(4):113-116.
[22]. Froes AM, dos Santos CVD, Penha-Filho ML,Teixeira MCA et al. Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigot antibodies of different animal species. Veterinary Immunol Immunopathol. 2004;99:135–141.
[23]. Chaves C S, Soares, DD, Da Siva R P, Saraiva EM. Characterization of the species-and stage specificity of two monoclonal antibodies against Leishmania amazonensis. Exp Parasitol. 2003; 103:152-159.
[24]. Thaı´s G.V. Silveira1, Erika Suzuki, Helio K.Takahashi, Anita H. Inhibition of macrophage invasion by monoclonal antibodies specific to Leishmania (Viannia) braziliensis promastigote and characterization of their antigens braziliensis. Int. J. Parasitol. 2001;31:1451–1458.